Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission

Background Subsequent risk of hepatocellular carcinoma (HCC) persists in chronic hepatitis B (CHB) patients with virological remission. We aimed to assess the cost-effectiveness of HCC surveillance in those patients and determine appropriate age to commence or discontinue surveillance. Methods We de...

Full description

Saved in:

Bibliographic Details
Published in:	BMC public health Vol. 24; no. 1; pp. 2202 - 12
Main Authors:	Fang, Kailu, Li, Shuwen, Lin, Yushi, Zhang, Yu, Wu, Jie
Format:	Journal Article
Language:	English
Published:	London BioMed Central 13.08.2024 BioMed Central Ltd Springer Nature B.V BMC
Subjects:	Ablation Adult Age Aged Barriers and facilitators to cancer screening Biostatistics Cancer Cancer therapies Carcinoma, Hepatocellular Care and treatment China - epidemiology Cirrhosis Cohort analysis Cost analysis Cost benefit analysis Cost effectiveness Development and progression Diagnosis Economic aspects Economics Environmental Health Epidemiology Female Fibrosis Hepatitis Hepatitis B Hepatitis B, Chronic - complications Hepatocellular carcinoma Hepatoma Humans Immunization Liver Liver cancer Liver cirrhosis Liver Cirrhosis - complications Liver diseases Liver Neoplasms Liver transplants Magnetic resonance imaging Male Medical prognosis Medicine Medicine & Public Health Methods Microsimulation modeling Middle Aged Patients Public Health Quality-Adjusted Life Years Radiation therapy Remission Remission (Medicine) Risk factors Risk groups Screening Simulation Surveillance Vaccine China United States > US Liver cancer Screening Microsimulation modeling Cost-effectiveness
ISSN:	1471-2458, 1471-2458
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!